Hauptseite > Workflowsammlungen > Öffentliche Einträge > Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus > print

001     281677
005     20220930130057.0
024 7 _ |a 10.1155/2015/569052
|2 doi
024 7 _ |a 2314-6133
|2 ISSN
024 7 _ |a 2314-6141
|2 ISSN
024 7 _ |a 2128/9799
|2 Handle
024 7 _ |a WOS:000364067900001
|2 WOS
024 7 _ |a altmetric:4746053
|2 altmetric
024 7 _ |a pmid:26568958
|2 pmid
037 _ _ |a FZJ-2016-01365
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-Juel1)131869
|a Hauptmann, Christian
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus
260 _ _ |a New York [u.a.]
|b Hindawi
|c 2015
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1454314178_19494
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Purpose. Primary tinnitus has a severe negative influence on the quality of life of a significant portion of the general population. Acoustic coordinated reset neuromodulation is designed to induce a long-lasting reduction of tinnitus symptoms. To test acoustic coordinated reset neuromodulation as a treatment for chronic, tonal tinnitus under real life conditions, an outpatient study “RESET Real Life” was commissioned by ANM GmbH. Herein we present the results of this study. Methods. In a prospective, open-label, nonrandomized, noncontrolled multicenter clinical study with 200 chronic tinnitus patients, tinnitus questionnaire TBF-12 and Global Clinical Improvement-Impression Scale (CGI-I7) are used to study the safety and efficacy of acoustic coordinated reset neuromodulation. 189 patients completed the last 12-month visit, 11 patients dropped out (8 because of nontreatment related reasons; 2 because tinnitus did not change; and 1 because tinnitus got louder). Results. Acoustic coordinated reset neuromodulation caused a statistically and clinically significant decrease in TBF-12 scores as well as in CGI-I7 after 12 months of therapy under real life conditions. There were no persistent adverse events reported that were related to the therapy. Conclusion. The field study “RESET Real Life” provides evidence for safety and efficacy of acoustic coordinated reset neuromodulation in a prospective, open-label, real life setting.
536 _ _ |0 G:(DE-HGF)POF2-89572
|a 89572 - (Dys-)function and Plasticity (POF2-89572)
|c POF2-89572
|f POF II T
|x 0
536 _ _ |0 G:(DE-Juel-1)BHG_T/Z4000.01.13_19022015
|a BHG-FZJ - Zusammenarbeits- und Lizenzoptionsvereinbarung zwischen Brook Henderson Group Limited und Forschungszentrum Jülich GmbH (BHG_T/Z4000.01.13_19022015)
|c BHG_T/Z4000.01.13_19022015
|x 1
588 _ _ |a Dataset connected to CrossRef
700 1 _ |0 P:(DE-HGF)0
|a Ströbel, Armin
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Williams, Mark
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Patel, Nitesh
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Wurzer, Hannes
|b 4
700 1 _ |0 P:(DE-HGF)0
|a von Stackelberg, Tatjana
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Brinkmann, Uwe
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Langguth, Berthold
|b 7
700 1 _ |0 P:(DE-Juel1)131884
|a Tass, Peter A.
|b 8
|u fzj
773 _ _ |0 PERI:(DE-600)2698540-8
|a 10.1155/2015/569052
|g Vol. 2015, p. 1 - 8
|p 569052
|t BioMed research international
|v 2015
|x 2314-6141
|y 2015
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/281677/files/569052.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:281677
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131869
|a Forschungszentrum Jülich GmbH
|b 0
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131884
|a Forschungszentrum Jülich GmbH
|b 8
|k FZJ
913 1 _ |0 G:(DE-HGF)POF2-89572
|a DE-HGF
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|1 G:(DE-HGF)POF3-890
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-800
|b Programmungebundene Forschung
|l ohne Programm
914 1 _ |y 2015
915 _ _ |0 LIC:(DE-HGF)CCBY3
|2 HGFVOC
|a Creative Commons Attribution CC BY 3.0
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b BIOMED RES INT : 2014
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 1 _ |a UNRESTRICTED
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 _ _ |a APC

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21